All Press Releases for January 23, 2019

Corporate Whistleblower Center Now Urges a Manager at A Drug Company to Call About Rewards If They Have Proof Their CEO Is Hiding Information About a Defective Drug to Protect Their Stock Price

The Corporate Whistleblower Center is urging a manager or researcher at a drug company to call them anytime at 866-714-6466 if the company is hiding information from the public and shareholders about a defective drug product. Be a hero-get rich!



"If you have this type of information and it is not yet public knowledge please call us at 866-714-6466. You could make millions off this type of not yet disclosed bad drug information."

    WASHINGTON, DC, January 23, 2019 /24-7PressRelease/ -- The Corporate Whistleblower Center is urging a manager at a publicly traded pharmaceutical company to call them anytime at 866-714-6466 if they possess proof their CEO or executive team is withholding negative or extremely damaging information about one of their drug products from their shareholders or consumers to protect the stock price value of the company.

The government via the SEC whistleblower reward program can in many instances provide whistleblowers who possess proof of withholding the truth from shareholders extremely significant rewards and it might be possible for the whistleblower to remain anonymous for revealing the information. http://CorporateWhistleblowerCenter.Com

The Corporate Whistleblower Center is urging a drug company manager, researcher, or executive with proof the executive team of a publicly traded pharmaceutical company is lying to their shareholders or consumers about negative results or information related to a drug product to call them anytime at 866-714-6466 if they have proof of the following:

* A pharmaceutical maker's drug product is killing or severely injuring consumers---the company knows it and they have not recalled the product or notified the FDA.
* A drug maker has recently become aware of severe side effects with a new drug product and they have concealed this information from the FDA and the general public.
* A drug company is bribing physicians to prescribe a defective drug or a drug that has not been approved by the FDA-for a new use.

According to the Corporate Whistleblower Center, "These are just a few types of examples where the executive team of a publicly traded pharmaceutical company could be lying to shareholders about huge liabilities and if you have this type of information and it is not yet public knowledge please call us at 866-714-6466. You could make millions off this type of information and we can help you make your information more valuable. Why sit on a potentially winning Super Lotto ticket without ever knowing what it might have been worth?" http://CorporateWhistleblower.Com

Simple rules for a whistleblower from the Corporate Whistleblower Center: Do not go to the SEC first if have information about a publicly traded company CEO or CFO lying to their shareholders. The Corporate Whistleblower Center says, "Major whistleblowers frequently go directly to the SEC or government thinking they will help. It's a huge mistake. Do not go to the news media with your whistleblower information either. Any type of public revelation of a whistleblower's information could destroy the prospect for a reward. Do not try to force a corporation to come clean about lying to their shareholders. Call us first at 866-714-6466 and if we think you have enough information we will help you get to some of the nation's top whistleblower attorneys."

The Corporate Whistleblower is the premier advocate for whistleblowers in the United States. Unlike any group in the US, they can assist a potential securities fraud whistleblower package their information provided the information is sufficient they will provide the whistleblower with access to some of the most accomplished whistleblower attorneys in the nation. For more information, a potential whistleblower in any state can contact the Corporate Whistleblower anytime at 866-714-6466 or visit http://CorporateWhistleblower.Com

For attribution please refer to the July 2017 Securities and Exchange Commission press release about a whistleblower reward: https://www.sec.gov/news/press-release/2017-134.

# # #

Contact Information

Thomas Martin
Corporate Whistleblower Center
Washington, DC
USA
Voice: 866-714-6466
E-Mail: Email Us Here
Website: Visit Our Website